Surgical Procedures, OperativePREVEMCANCT04013061
Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery
A study testing Pluridisciplinary consultation in people with Surgical Procedures, Operative, run by Centre Hospitalier Universitaire de Nīmes at 3 sites in France.
Trial summary
The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Surgical Procedures, Operative
- What is being tested?
- Pluridisciplinary consultation
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 378 participants
- Where
- 3 sitesFrance
- Study dates
- 25 Feb 2020to 30 Sep 2021
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- The patient must have given their free and informed consent
- The patient must be a member or beneficiary of a health insurance plan
- The patient has at least one chronic medication prescription (associated with a chronic illness)
- The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse
Who cannot join
- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- The patient is having ambulatory programmed surgery
- The patient has an anesthetic consultation in a different health establishment
Trial locations and contacts
3 sites in 1 country.
France3 sites
CHU de Montpellier
Montpellier, 34090
CHU de Nimes
Nîmes, 30029
CHU de Toulouse
Toulouse
About this study
The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery
- Conditions
- Surgical Procedures, Operative
- Being tested
- Pluridisciplinary consultation
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Pluridisciplinary consultationOther
Pharmacist-anesthesiologist team will be present during the anesthetic consultation
| Study group | Role | What they receive |
|---|---|---|
| Standard consultation | No intervention | Not described |
| Pharmacist-anesthesiologist consultation | Experimental | Not described Receives: Other: Pluridisciplinary consultation |
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of patients with at least one medication error for chronic treatment
%
Measured: 48 hours post-admission
Secondary outcomes (8)
Nature of medication error
According to REMED (Revue des Erreurs liées aux Médicaments Et Dispositifs médicaux) classification
Measured: 48 hours post-admission
Rate of medication errors corrected
%
Measured: 48 hours post-admission
Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations
%
Measured: 48 hours post-admission
Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018
%
Measured: 48 hours post-admission
Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery
%
Measured: 48 hours post-admission
Rate of medications not available on the establishment's therapeutic book and not brought by the patient
%
Measured: 48 hours post-admission
Duration in hospital
Days
Measured: End of hospitalization (max 30 days)
Rate of delay or cancellation of surgery linked to preoperational medication error
%
Measured: End of study (13 months)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Jul 2019
- Study start25 Feb 2020
- Primary completion20 Aug 2021
- Study completion30 Sep 2021
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Surgical Procedures, OperativeStudies of the same condition, open and under way.
- More trials run by Centre Hospitalier Universitaire de NīmesThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 378 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Universitaire de Nīmes
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Géraldine Leguelinel-Blache, Study director, CHU Nimes
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04013061
- Sponsor's protocol ID
- PHRCI/2018/GL-01
- Acronym
- PREVEMCA
- Status last verified
- Mar 2022
- First submitted
- 5 Jul 2019
- Last updated
- 11 Dec 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Dec 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery
- ClinicalTrials.gov ID
- NCT04013061
- Acronym / sponsor ID
- PREVEMCA / PHRCI/2018/GL-01
- Conditions
- Surgical Procedures, Operative
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 378 participants (actual)
- Lead sponsor
- Centre Hospitalier Universitaire de NīmesUniversity, hospital or other
- Study start
- 25 Feb 2020 (actual)
- Primary completion
- 20 Aug 2021 (actual)
- Study completion
- 30 Sep 2021 (actual)
- First posted
- 9 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Standard consultation | No intervention | – |
| Pharmacist-anesthesiologist consultation | Experimental | Other: Pluridisciplinary consultation |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- The patient must have given their free and informed consent
- The patient must be a member or beneficiary of a health insurance plan
- The patient has at least one chronic medication prescription (associated with a chronic illness)
- The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse
Key exclusion criteria (6 listed)
- The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
- The subject refuses to sign the consent
- It is impossible to give the subject informed information
- The patient is under safeguard of justice or state guardianship
- The patient is having ambulatory programmed surgery
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Pluridisciplinary consultationPharmacist-anesthesiologist team will be present during the anesthetic consultation | Other | Pharmacist-anesthesiologist consultation |
Primary outcome
Rate of patients with at least one medication error for chronic treatment
Time frame: 48 hours post-admission
%
8 secondary outcomes
Nature of medication error
Time frame: 48 hours post-admission
Rate of medication errors corrected
Time frame: 48 hours post-admission
Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations
Time frame: 48 hours post-admission
Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018
Time frame: 48 hours post-admission
Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery
Time frame: 48 hours post-admission
Rate of medications not available on the establishment's therapeutic book and not brought by the patient
Time frame: 48 hours post-admission
Duration in hospital
Time frame: End of hospitalization (max 30 days)
Rate of delay or cancellation of surgery linked to preoperational medication error
Time frame: End of study (13 months)
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Dec 2025.
Related trials for Surgical Procedures, Operative
Active, not recruiting
Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes
Common Femoral Artery Stenosis, Calcification; Heart
RecruitingPhase 2/3
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Not yet recruitingObservational study
Systematic Intraoperative Cell Salvage in On-Pump Cardiac Surgery Within a Mature Patient Blood Management Programme
Cardiac Surgical Procedures, Blood Transfusion
Not yet recruitingObservational study
Pilot Study on the Effectiveness and Safety of OPTILENE® SILVER MESH ELASTIC in Prevention of Surgical Site Infection (SSI) and Incisional Hernia (IH)
Abdominal Aortic Aneurysm, Morbid Obesity
Recruiting
68Ga-XMFH01 PET/Fluorescence Imaging in Prostate Cancer
Prostate Cancer (Diagnosis), ACP3
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Géraldine Leguelinel-Blache study director
CHU Nimes
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Pluridisciplinary consultation in people with Surgical Procedures, Operative, run by Centre Hospitalier Universitaire de Nīmes at 3 sites in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 11 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of patients with at least one medication error for chronic treatment (time frame: 48 hours post-admission). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Dec 2025.